File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: GPRC5A promotes lung colonization of esophageal squamous cell carcinoma

TitleGPRC5A promotes lung colonization of esophageal squamous cell carcinoma
Authors
Issue Date16-Nov-2024
PublisherSpringer Nature
Citation
Nature Communications, 2024, v. 15, n. 1 How to Cite?
AbstractEmerging evidence suggests that cancer cells may disseminate early, prior to the formation of traditional macro-metastases. However, the mechanisms underlying the seeding and transition of early disseminated cancer cells (DCCs) into metastatic tumors remain poorly understood. Through single-cell RNA sequencing, we show that early lung DCCs from esophageal squamous cell carcinoma (ESCC) exhibit a trophoblast-like ‘tumor implantation’ phenotype, which enhances their dissemination and supports metastatic growth. Notably, ESCC cells overexpressing GPRC5A demonstrate improved implantation and persistence, resulting in macro-metastases in the lungs. Clinically, elevated GPRC5A level is associated with poorer outcomes in a cohort of 148 ESCC patients. Mechanistically, GPRC5A is found to potentially interact with WWP1, facilitating the polyubiquitination and degradation of LATS1, thereby activating YAP1 signaling pathways essential for metastasis. Importantly, targeting YAP1 axis with CA3 or TED-347 significantly diminishes early implantation and macro-metastases. Thus, the GPRC5A/WWP1/LATS1/YAP1 pathway represents a crucial target for therapeutic intervention in ESCC lung metastases.
Persistent Identifierhttp://hdl.handle.net/10722/358460
ISSN
2023 Impact Factor: 14.7
2023 SCImago Journal Rankings: 4.887

 

DC FieldValueLanguage
dc.contributor.authorZhou, Hongyu-
dc.contributor.authorTan, Licheng-
dc.contributor.authorZhang, Baifeng-
dc.contributor.authorKwong, Dora Lai Wan-
dc.contributor.authorWong, Ching Ngar-
dc.contributor.authorZhang, Yu-
dc.contributor.authorRu, Beibei-
dc.contributor.authorLyu, Yingchen-
dc.contributor.authorSiu, Kin To Hugo-
dc.contributor.authorLuo, Jie-
dc.contributor.authorYang, Yuma-
dc.contributor.authorLiu, Qin-
dc.contributor.authorChen, Yixin-
dc.contributor.authorZhang, Weiguang-
dc.contributor.authorHe, Chaohui-
dc.contributor.authorJiang, Peng-
dc.contributor.authorQin, Yanru-
dc.contributor.authorLiu, Beilei-
dc.contributor.authorGuan, Xin Yuan-
dc.date.accessioned2025-08-07T00:32:28Z-
dc.date.available2025-08-07T00:32:28Z-
dc.date.issued2024-11-16-
dc.identifier.citationNature Communications, 2024, v. 15, n. 1-
dc.identifier.issn2041-1723-
dc.identifier.urihttp://hdl.handle.net/10722/358460-
dc.description.abstractEmerging evidence suggests that cancer cells may disseminate early, prior to the formation of traditional macro-metastases. However, the mechanisms underlying the seeding and transition of early disseminated cancer cells (DCCs) into metastatic tumors remain poorly understood. Through single-cell RNA sequencing, we show that early lung DCCs from esophageal squamous cell carcinoma (ESCC) exhibit a trophoblast-like ‘tumor implantation’ phenotype, which enhances their dissemination and supports metastatic growth. Notably, ESCC cells overexpressing GPRC5A demonstrate improved implantation and persistence, resulting in macro-metastases in the lungs. Clinically, elevated GPRC5A level is associated with poorer outcomes in a cohort of 148 ESCC patients. Mechanistically, GPRC5A is found to potentially interact with WWP1, facilitating the polyubiquitination and degradation of LATS1, thereby activating YAP1 signaling pathways essential for metastasis. Importantly, targeting YAP1 axis with CA3 or TED-347 significantly diminishes early implantation and macro-metastases. Thus, the GPRC5A/WWP1/LATS1/YAP1 pathway represents a crucial target for therapeutic intervention in ESCC lung metastases.-
dc.languageeng-
dc.publisherSpringer Nature-
dc.relation.ispartofNature Communications-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleGPRC5A promotes lung colonization of esophageal squamous cell carcinoma-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1038/s41467-024-54251-9-
dc.identifier.pmid39550386-
dc.identifier.scopuseid_2-s2.0-85209385575-
dc.identifier.volume15-
dc.identifier.issue1-
dc.identifier.eissn2041-1723-
dc.identifier.issnl2041-1723-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats